Dimensional Fund Advisors
CBIO

Dimensional Fund Advisors’s Crescent Biopharma CBIO Stock Holding History

Dimensional Fund Advisors’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-232
Closed -$69.5K – 3391
2024
Q1 		$69.5K Buy
+232
New +$69.3K ﹤0.01% 3303
2023
Q4 		– Sell
-445
Closed -$66.8K – 3432
2023
Q3 		$66.8K Hold
445
– – ﹤0.01% 3359
2023
Q2 		$77.5K Sell
445
-223
-33% -$37.4K ﹤0.01% 3361
2023
Q1 		$84.1K Buy
+668
New +$150K ﹤0.01% 3326
2022
Q2 		– Sell
-2,711
Closed -$309K – 3492
2022
Q1 		$309K Sell
2,711
-2,933
-52% -$344K ﹤0.01% 3243
2021
Q4 		$813K Sell
5,644
-3,402
-38% -$617K ﹤0.01% 3073
2021
Q3 		$1.98M Sell
9,046
-2,743
-23% -$581K ﹤0.01% 2857
2021
Q2 		$2.73M Sell
11,789
-357
-3% -$90.9K ﹤0.01% 2792
2021
Q1 		$3.66M Buy
12,146
+65
+0.5% +$23.3K ﹤0.01% 2676
2020
Q4 		$4.54M Buy
12,081
+112
+0.9% +$39.2K ﹤0.01% 2555
2020
Q3 		$3.67M Buy
11,969
+188
+2% +$71.9K ﹤0.01% 2552
2020
Q2 		$4.43M Buy
11,781
+28
+0.2% +$7.93K ﹤0.01% 2517
2020
Q1 		$2.68M Buy
11,753
+1,263
+12% +$483K ﹤0.01% 2614
2019
Q4 		$5.55M Buy
10,490
+93
+0.9% +$50.3K ﹤0.01% 2578
2019
Q3 		$4.48M Buy
10,397
+524
+5% +$337K ﹤0.01% 2638
2019
Q2 		$11.8M Buy
9,873
+1,203
+14% +$1.44M ﹤0.01% 2332
2019
Q1 		$10.8M Buy
8,670
+2,496
+40% +$2.86M ﹤0.01% 2375
2018
Q4 		$5.85M Buy
6,174
+2,286
+59% +$2.75M ﹤0.01% 2554
2018
Q3 		$5.6M Buy
+3,888
New +$5.88M ﹤0.01% 2644

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors's CBIO Position: Q2 2024 in Review

Dimensional Fund Advisors sold out of Crescent Biopharma (CBIO) in Q2 2024, closing a stake of 232 shares — an estimated $69.5K sold.

Dimensional Fund Advisors first reported a position in CBIO in Q3 2018 and held it in 19 quarters. The position peaked at $11.8M in Q2 2019. 35 funds tracked by Wall St. Rank hold CBIO as of Q2 2024.

  • Dimensional Fund Advisors reported no remaining Crescent Biopharma position as of Q2 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 232 Crescent Biopharma shares in Q2 2024, an estimated $69.5K.
  • Dimensional Fund Advisors first reported a position in Crescent Biopharma in Q3 2018 and held it in 19 quarters.
  • Dimensional Fund Advisors's Crescent Biopharma position peaked at $11.8M in Q2 2019.
  • 35 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2024.

Based on Dimensional Fund Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.